Literature DB >> 18455153

Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.

J A P van de Nes1, R Nafe, W Schlote.   

Abstract

In Alzheimer's disease (AD), cortical neurons develop neurofibrillary tangles (NFTs) consisting of hyperphosphorylated tau. The neurons eventually die. There are some hints that cortical neurons may also degenerate without the development of cytoskeletal changes. We investigated this possibility by comparing changes in APP staining and neuronal size with respect to the presence or absence of hyperphosphorylated tau. Adjacent sections of the medial temporal neocortex (Brodmann's area 22) of 5 male AD patients aged 60-88 years (Braak V-VI) and 5 age-matched male non-demented control subjects were i) stained with a modified Bielschowsky silver method in order to reveal NFTs and 'ghost' tangles, ii) single-stained with anti-APP, and iii) double-labeled with anti-APP and AT8. Anti-APP is directed against the beta-amyloid precursor protein and stains virtually all perikarya and proximal neurites of the cortical neurons. AT8 stains pre-tangles, NFTs and extracellular 'ghost' tangles due to the recognition of hyperphosphorylated tau. The study was focused on the supragranular cortical layers II-III, since these layers can be clearly delineated from the adjacent molecular and granular cell layers. The results showed that i) APP staining intensity in neurons was variable in the AD cortex, being clearly different from the invariably intense neuronal staining in all controls. Reduced cytoplasmic APP staining was observed, particular in small neurons, while lack of anti-APP staining in proximal neurites, too, was associated with AD. In addition, ii) cross-sectional area measurement on anti-APP-stained neurons revealed that in AD, as compared to controls, a clear decrease in the number of mainly large-sized neurons (>150 microm2) was accompanied by a significant increase in the percentage of neurons in the smaller size classes, indicating that many large-sized neurons became smaller in AD. iii) Reduced APP staining and decreased neuronal size were not necessarily associated with the presence or absence of hyperphosphorylated tau in these cells. iv) Twenty-six percent of the neurons contained hyperphosphorylated tau, while the level of NFT-related neuronal loss was low in AD. The present study suggests that non-tau based neuronal degeneration is a major phenomenon in the AD neocortex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455153     DOI: 10.1016/j.brainres.2008.03.043

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Authors:  Jean C Augustinack; Kristen E Huber; Gheorghe M Postelnicu; Sita Kakunoori; Ruopeng Wang; André J W van der Kouwe; Lawrence L Wald; Thor D Stein; Matthew P Frosch; Bruce Fischl
Journal:  Acta Neuropathol       Date:  2011-12-13       Impact factor: 17.088

Review 2.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

Review 3.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

4.  Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer's Disease.

Authors:  Micaela E Consens; Yuxiao Chen; Vilas Menon; Yanling Wang; Julie A Schneider; Philip L De Jager; David A Bennett; Shreejoy J Tripathy; Daniel Felsky
Journal:  Front Mol Neurosci       Date:  2022-06-10       Impact factor: 6.261

5.  Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.

Authors:  Marius Chiasseu; Jorge L Cueva Vargas; Laurie Destroismaisons; Christine Vande Velde; Nicole Leclerc; Adriana Di Polo
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

6.  Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease.

Authors:  Qinan Zhang; Teng Gao; Yi Luo; Xijuan Chen; Ge Gao; Xiaoqun Gao; Yiwu Zhou; Jiapei Dai
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 7.  Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease.

Authors:  Marcos J Guerrero-Muñoz; Julia Gerson; Diana L Castillo-Carranza
Journal:  Front Cell Neurosci       Date:  2015-12-02       Impact factor: 5.505

8.  Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis.

Authors:  Gianluca Coppola; Antonio Di Renzo; Lucia Ziccardi; Francesco Martelli; Antonello Fadda; Gianluca Manni; Piero Barboni; Francesco Pierelli; Alfredo A Sadun; Vincenzo Parisi
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

9.  Characterization of tau oligomeric seeds in progressive supranuclear palsy.

Authors:  Julia E Gerson; Urmi Sengupta; Cristian A Lasagna-Reeves; Marcos J Guerrero-Muñoz; Juan Troncoso; Rakez Kayed
Journal:  Acta Neuropathol Commun       Date:  2014-06-14       Impact factor: 7.801

10.  Alzheimers disease: review of emerging treatment role for intravenous immunoglobulins.

Authors:  Rakez Kayed; George R Jackson; D Mark Estes; Alan D T Barrett
Journal:  J Cent Nerv Syst Dis       Date:  2011-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.